Obalon Therapeutics, Inc. logo
Obalon Therapeutics, Inc. OBLN

Obalon Therapeutics, Inc. Long-Term Debt 2011-2025 | OBLN

Long-term debt is a financial obligation of a company or an individual with a repayment period exceeding one year from the date it arises. In accounting, such obligations are recorded under the "long-term liabilities" section.

Main characteristics:
  • Term exceeds 12 months
  • Can take the form of bonds, bank loans, credit lines, leasing, or loans from affiliated parties
  • Repaid through regular payments (interest and/or principal) over several years
Why long-term debt is needed:
  • Investment in development
    Allows financing of large projects — new factories, production lines, innovative developments — without diverting working capital.
  • Smoothing of cash flows
    A long-term payment schedule facilitates budget planning and reduces short-term financial risks.
  • Optimization of capital structure
    A combination of equity and borrowed capital can reduce the average cost of business financing.

A high level of long-term debt may indicate that a company heavily relies on borrowed funds. This increases risks, especially in conditions of rising interest rates or declining profits. However, a moderate level of debt can signal a sound growth strategy — for example, the company takes a loan to expand its business.

If a company uses borrowed funds effectively (e.g., invests in profitable projects), this can lead to profit growth and, consequently, an increase in stock value. An investor evaluates whether the investments made using debt are paying off.

It is important to monitor whether the company can regularly pay interest and repay the principal. Payment difficulties can lead to reduced dividends, a drop in stock value, and even bankruptcy.

Examples of long-term debt:
  • Mortgage loans for property purchases
  • Corporate bonds issued by a company to raise capital
  • Project financing — long-term loans for building or expanding production facilities
  • Leasing obligations for equipment or transport

Annual Long-Term Debt Obalon Therapeutics, Inc.

2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
430 K - - 7.96 M 9.88 M 9.09 M 4.88 M - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
9.88 M 430 K 6.45 M

Long-Term Debt of other stocks in the Medical devices industry

Issuer Long-Term Debt Price % 24h Market Cap Country
GenMark Diagnostics, Inc. GenMark Diagnostics, Inc.
GNMK
71.3 M - - $ 1.77 B usaUSA
Abiomed Abiomed
ABMD
3.66 M - - $ 17.2 B usaUSA
Acutus Medical Acutus Medical
AFIB
32.7 M - -26.83 % $ 2.62 M usaUSA
Apyx Medical Corporation Apyx Medical Corporation
APYX
33.2 M $ 3.82 -1.04 % $ 132 M usaUSA
Bio-Rad Laboratories Bio-Rad Laboratories
BIO
1.2 B $ 307.08 -0.33 % $ 8.66 B usaUSA
Apollo Endosurgery Apollo Endosurgery
APEN
34 M - - $ 475 M usaUSA
BioSig Technologies BioSig Technologies
BSGM
103 K - 37.08 % $ 85.7 M usaUSA
Bruker Corporation Bruker Corporation
BRKR
2.06 B $ 45.69 1.24 % $ 6.81 K usaUSA
Allied Healthcare Products Allied Healthcare Products
AHPI
2.93 K - 3.58 % $ 2.21 M usaUSA
Abbott Laboratories Abbott Laboratories
ABT
12.6 B $ 128.67 2.55 % $ 224 B usaUSA
Boston Scientific Corporation Boston Scientific Corporation
BSX
8.97 B $ 91.95 -0.67 % $ 135 B usaUSA
Conformis Conformis
CFMS
20.6 M - - $ 16.4 M usaUSA
CryoLife, Inc. CryoLife, Inc.
CRY
290 M - -4.14 % $ 702 M usaUSA
EDAP TMS S.A. EDAP TMS S.A.
EDAP
2.16 M $ 3.18 10.56 % $ 119 M franceFrance
Cardiovascular Systems Cardiovascular Systems
CSII
1.33 M - 0.15 % $ 844 M usaUSA
Cutera Cutera
CUTR
1.06 M - -10.19 % $ 1.99 M usaUSA
Itamar Medical Ltd. Itamar Medical Ltd.
ITMR
154 K - 0.03 % $ 1.58 B israelIsrael
Misonix, Inc. Misonix, Inc.
MSON
38.6 M - - $ 462 M usaUSA
Neovasc Neovasc
NVCN
7.64 M - - $ 111 M canadaCanada
Eargo Eargo
EAR
11.9 M - - $ 10.2 M usaUSA
Dynatronics Corporation Dynatronics Corporation
DYNT
1.11 M - 14.99 % $ 929 K usaUSA
Intersect ENT, Inc. Intersect ENT, Inc.
XENT
63.6 M - - $ 955 M usaUSA
Cognyte Software Ltd. Cognyte Software Ltd.
CGNT
24.1 M $ 9.58 -2.84 % $ 688 M israelIsrael
IRIDEX Corporation IRIDEX Corporation
IRIX
1.75 M $ 0.99 7.52 % $ 16 M usaUSA
IRadimed Corporation IRadimed Corporation
IRMD
1.42 K $ 96.99 0.79 % $ 1.23 B usaUSA
Second Sight Medical Products Second Sight Medical Products
EYES
18 M - -0.97 % $ 54.4 M usaUSA
Align Technology Align Technology
ALGN
88.2 M $ 163.04 -1.44 % $ 12.2 B usaUSA
Accuray Incorporated Accuray Incorporated
ARAY
124 M $ 1.04 -2.06 % $ 107 M usaUSA
Avinger Avinger
AVGR
1.1 M - -20.74 % $ 369 K usaUSA
ClearPoint Neuro ClearPoint Neuro
CLPT
3.01 M $ 12.5 -1.66 % $ 338 M usaUSA
FONAR Corporation FONAR Corporation
FONR
155 K $ 14.9 0.99 % $ 97.7 M usaUSA
AxoGen AxoGen
AXGN
47.5 M $ 30.0 -1.3 % $ 1.33 B usaUSA
Axonics Modulation Technologies Axonics Modulation Technologies
AXNX
7.56 M - - $ 3.31 B usaUSA
GBS GBS
GBS
1.65 M - -0.57 % $ 7.12 M usaUSA
CONMED Corporation CONMED Corporation
CNMD
905 M $ 40.3 -1.29 % $ 1.24 B usaUSA
LivaNova PLC LivaNova PLC
LIVN
550 M $ 63.28 0.84 % $ 3.43 B britainBritain
OrthoPediatrics Corp. OrthoPediatrics Corp.
KIDS
73 M $ 17.83 1.31 % $ 411 M usaUSA
Globus Medical Globus Medical
GMED
298 K $ 86.73 0.05 % $ 11.8 B usaUSA
LENSAR LENSAR
LNSR
2.09 M $ 11.51 -0.04 % $ 133 M usaUSA
Integra LifeSciences Holdings Corporation Integra LifeSciences Holdings Corporation
IART
760 M $ 13.51 0.67 % $ 1.04 B usaUSA
Aziyo Biologics Aziyo Biologics
AZYO
20.4 M - 1.37 % $ 20.5 M usaUSA
Alphatec Holdings Alphatec Holdings
ATEC
575 M $ 19.79 -0.85 % $ 2.83 B usaUSA
Aethlon Medical Aethlon Medical
AEMD
337 K $ 3.07 -9.71 % $ 4.79 M usaUSA
Establishment Labs Holdings Establishment Labs Holdings
ESTA
220 M $ 72.39 -0.17 % $ 2.04 B costa-ricaCosta-rica